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diagnosed as patients with subclinical hypothyroidism if 
TSH level was higher than 4.0 μIU/ml with normal levels 
of fT3 and fT4. Group II. Patients with autoimmune thy-
roiditis and overt hypothyroidism. It included 49 patients 
(13 male (26.5 %) and 36 female (73.5 %)), their mean 
ages 48.16 ± 3.19 years. They were diagnosed as patients 
with overt hypothyroidism if TSH level was higher than 
4.0 μIU/ml with lower levels of fT3 and fT4 than nor-
mal value. Group III. Control group included 20 appar-
ently healthy individuals (3 male (15 %) and 17 female 
(85 %)), their mean ages are 47.20 ± 2.78 years. They 
were not complaining from any chronic medical diseases 
with normal clinical examinations, no history of thyroid 
diseases or any chronic illness may interfere with our re-
sults. They were not on vitamin D supplements.
Results. Levels of serum TSH were significantly in-
creased in subclinical (6.80 ± 1.84 μIU/ml) and hypo-
thyroid (10.24 ± 2.09 μIU/ml) groups as compared to 
control group (2.16 ± 0.39 μIU/ml) (p < 0.05). The thy-
roid peroxidase antibodies level was 312.83 ± 7.19 IU/ml 
in subclinical hypothyroid group and was 529.31 ± 
± 9.62 IU/ml in the hypothyroid group. The levels of 
serum total 25(OH)D were significantly decreased in 
subclinical (21.9 ± 1.1 nmol/L) and overt hypothy-
roid groups (18.8 ± 1.2 nmol/L) as compared to control 
group (27.1 ± 1.2 nmol/L) (p < 0.05). A highly signifi-
cant negative correlation was found between serum TSH, 
thyroid peroxidase antibodies and total 25(OH)D levels 
(p < 0.001). Also highly significant positive correlation 
was found between the levels of serum total 25(OH)D 
and serum fT4 (p < 0.001). There was significant posi-
tive correlation between TSH and thyroid peroxidase an-
tibodies levels (p < 0.05).
Conclusions. We showed, that there was a highly sig-
nificant decrease in (25OH)D levels in autoimmune thy-
roiditis patients both in the subclinical and overt hypo-
thyroid groups as compared to control group. A highly 
significant negative correlation was found between serum 
TSH, thyroid peroxidase antibodies and total 25(OH)D 
levels. Also highly significant positive correlation was 
found between the levels of serum total 25(OH)D and se-
rum fT4.
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Introduction. The occurrence of osteoarthrosis (OA) in 
young people in most cases is the result of injuries (more 
often sports) or overweight. Also, one of the concepts of 
development is cell activation, which is accompanied by 
an increased destruction of cartilage and decreased of ma-
trix synthesis. Cytokines and growth factors influence on 
chondrocytes through specific signaling pathways that reg-
ulate the synthesis of matrix metalloproteinases. Chang-
es in chondrocytes can disrupt the processes of differen-
tiation and lead to the synthesis of matrix cartilage is not 
enough high quality. A possible next step of the progres-
sion OA is the formation of osteoporosis (OP). One of the 
ways of OP development may be genetic deviation of the 
FDPS gene. Diphosphates, which structure includes ni-
trogen, are inhibitors of the enzyme FDPS, which plays a 
significant role in the synthesis of cholesterol and triggers 
apoptosis of osteoblasts. Changes in the given gene pro-
voke decrease in bone mass and bone density.
Aim: To determine the frequency of pathological muta-
tions of the FDPS gene in patients with osteoarthrosis as a 
marker of the formation of osteoporosis.
Materials and methods. Were examined 32 patients 
with OA at the age of 21 to 39 years and disease duration 
from 2 to 17 years. In 15 cases, it was preceded by the ap-
pearance of chronic rheumatism of the lower limbs (ath-
letes), in 9 cases, it developed against the background of 
obesity 2–3 stage. All patients underwent clinical, radiolog-
ical and densitometric study. DNA diagnostics were stud-
ied in blood leukocytes, which included a study of the in-
sertion-deletion polymorphism of FDPS gene — method of 
polymerase chain reaction with using a diagnostic test sys-
tems SNP-Express ACE Alu Ins/Del (Liteh, Russia).
The control group included 50 practically healthy per-
sons of similar age and sex.
Results. The study showed that in 9 cases OA changes 
at densitometric study has not been identified; 11 patients 
(34.4 %) were diagnosed with osteopenia and 12 (37.5 %) — 
osteoporosis of different severity. In the study of polymor-
phism of FDPS gene was found that in patients with normal 
densitometry genotype A/A was found in 5 cases (55.6 %), 
genotype A/C was identified in 3 patients (33.3 %) and 
patho logical C/C genotype in 1 (11.1 %). In the group of pa-
tients with osteopenia and OA — normal genotype was found 
in 2 cases (18.2 %); genotype A/C in 6 patients (54.5 %) and 
pathological genotype (C/C) of the FDPS gene in 3 patients 
(27.3 %). In the group of patients with OP has increased fre-
quency of pathological mutations (C/C genotype) to 66.7 % 
(8 patients); and genotype A/C was set at 4 patients (33.3 %). 
In studying of the prevalence of the FDPS gene of the healthy 
patients were received the following results: A/A genotype 
was recorded in 68 % (34 patients), A/C — in 24 % (12) and 
C/C — 8 % (4 patients).
Thus, patients with OA and osteopenia in 3.4 times fre-
quently were recorded pathological mutation of FDPS gene 
in comparison with those of the control group. In patients 
with OA and osteoporosis this indicator was in 8.3 times 
higher.
Conclusion. In young patients with OA often deter-
mined violation of the structure of bone tissue, leading to 
the formation of osteopenia (11 patients — 34.4 %) or os-
teoporosis (12 — 37.5 %). Development of such changes 
in bone tissue occurs against pathological mutation of the 
FDPS gene (genotype C/C).
Thus, the study variants of the FDPS gene in patients with 
OA can be used as a marker for the formation of osteoporosis, 
which allows to develop measures for its prevention.
